• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Johnson & Johnson Development Corporation

edit

Johnson & Johnson Development Corporation (JJDC) is the venture capital subsidiary of Johnson & Johnson. JJDC is comprised of experts and leaders in the health care and technology venture communities who identify early market indicators, health care trends, and strategic investment opportunities. Unlike traditional venture capital firms, JJDC determines the success of an investment’s performance not only in financial returns, but also in the viability of providing strategic growth options for Johnson & Johnson.

Recent Milestones

edit

• 
  Johnson & Johnson Development Corporation invested in Aquinox Pharmaceuticals. (4/3/13)
  Posted 4/8/13 at 11:55pm via yahoo.com
• 
  Johnson & Johnson Development Corporation invested in Nevro. (3/7/13)
  Posted 3/7/13 at 6:40pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in Genocea Biosciences. (10/10/12)
  Posted 10/10/12 at 7:37pm via masshightech.com
• 
  Johnson & Johnson Development Corporation invested in Astute Medical. (6/7/12)
  Posted 6/7/12 at 6:26pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in PhaseBio Pharmaceuticals. (6/5/12)
  Posted 6/5/12 at 6:19pm via dowjones.com
• 
  Johnson & Johnson Development Corporation invested in Mitralign. (5/16/12)
  Posted 5/16/12 at 5:54pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in Celladon. (2/15/12)
  Posted 2/15/12 at 6:31pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in Biocartis. (11/17/11)
  Posted 11/17/11 at 6:17pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in Nevro. (7/19/11)
  Posted 7/19/11 at 7:40pm via finsmes.com
• 
  Johnson & Johnson Development Corporation invested in Astute Medical. (3/8/11)
  Posted 3/8/11 at 7:26pm via msn.com
• 
  Johnson & Johnson Development Corporation invested in 23andMe. (11/9/10)
  Posted 11/9/10 at 6:29am via techcrunch.com
• 
  Johnson & Johnson Development Corporation invested in Breathe Technologies. (5/20/10)
  Posted 5/21/10 at 1:41am via onbiovc.com
• 
  Johnson & Johnson Development Corporation invested in Astute Medical. (5/12/10)
  Posted 5/11/10 at 10:14pm via onbiovc.com
• 
  Johnson & Johnson Development Corporation invested in Biocartis. (4/8/10)
  Posted 7/8/10 at 8:39pm via biocartis.com
• 
  Johnson & Johnson Development Corporation invested in Neotract. (9/15/09)
  Posted 9/18/09 at 5:03am via onbiovc.com
• 
  Johnson & Johnson Development Corporation invested in Neurosearch. (8/17/09)
  Posted 9/28/09 at 2:00am via neurosearch.com

Investments

Videos

Sources

1. Aquinox Pharmaceuticals Completes US $18 million Series C Financing (finance.yahoo.com) [edit]
2. Nevro Raises $48M in Series C Financing (finsmes.com) [edit]
3. Genocea raises $30M to advance herpes vaccine (masshightech.com) [edit]
4. Astute Medical Completes $40.4M Series C Financing (finsmes.com) [edit]
5. PhaseBio Pharmaceuticals Books $23M in Third Tranche of Series B (pevc.dowjones.com) [edit]
6. Mitralign Closes $35M in Series D Financing (finsmes.com) [edit]
7. Celladon Closes $43M in Funding (finsmes.com) [edit]
8. Biocartis Completes €71M Series C Equity Funding (finsmes.com) [edit]
9. Nevro Completes $58M Financing (finsmes.com) [edit]
10. Astute Medical Completes $13 Million Financing With Existing Stockholders (money.msn.com) [edit]
11. Personal Genetics Startup 23andMe Raises $22 Million More From Google, Others (techcrunch.com) [edit]
12. Breathe Technologies, Inc.: Series C $23M (onbiovc.com) [edit]
13. Astute Medical, Inc.: Series B $26.5M (onbiovc.com) [edit]
14. Biocartis raises €30 million in Series ‘B' financing round (biocartis.com) [edit]
15. Neotract, Inc.: Series B $23.7M (onbiovc.com) [edit]
16. NeuroSearch announces drug discovery and drug development alliance with Janssen Pharmaceutica NV (neurosearch.com) [edit]
17. Pronota (pronota.com) [edit]
18. CoAxia, Inc.: Series D $21.5M (onbiovc.com) [edit]
19. SEC (sec.gov) [edit]
20. Catalyst Biosciences Raises $40 Million in Series C Financing (fiercebiotech.com) [edit]
21. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
22. MOLECULAR PARTNERS SECURES $15.56 million IN SERIES A FINANCING (molecularpartners.com) [edit]
23. Novocell Raises $25 Million (novocell.com) [edit]
24. Metabolex (Metabolex.com) [edit]
25. EDGAR [edit]
26. Pronota (pronota.com) [edit]
27. BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING (biolex.com) [edit]
28. Tengion Inc. Completes $39 Million Series "A" Round Financing Will Advance Development of Regenerative Medicine Products (phx.corporate-ir.net) [edit]
29. EDGAR [edit]